Logotype for Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) investor relations material

Ginkgo Bioworks Q2 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Ginkgo Bioworks Holdings Inc
Q2 2025 earnings summary7 Aug, 2025

Executive summary

  • Achieved $250M annualized cost savings ahead of schedule through restructuring and site consolidation, maintaining $474M in cash and no bank debt.

  • Transitioned toward life science tools and automation, launching new products and expanding into academic and direct-to-scientist markets.

  • Net loss for Q2 2025 was $60M, a 72% improvement year-over-year, driven by lower R&D and G&A expenses.

  • Restructuring actions, including workforce reductions and facility consolidations, are expected to further improve cash flow and Adjusted EBITDA.

  • Platform demand is growing in biopharma, government, and academic sectors, with new automation and CRO services gaining traction.

Financial highlights

  • Q2 2025 total revenue was $49–$50M, with Cell Engineering up 8% to $39M and Biosecurity down 48% to $10M.

  • Adjusted EBITDA loss improved to $(28)M from $(99)M year-over-year, a 72% improvement.

  • Cash burn reduced to $38–$44M in Q2 2025 from $104–$110M in the prior year.

  • Total operating expenses dropped 41% year-over-year to $115M, mainly due to reduced R&D and G&A costs.

  • Six months ended June 30, 2025, included $7.5M non-cash revenue from a BiomEdit contract termination.

Outlook and guidance

  • Reaffirmed 2025 total revenue guidance of $167M–$187M; Cell Engineering $117M–$137M; Biosecurity at least $40M.

  • Targeting Adjusted EBITDA breakeven by end of 2026, with further cost levers and revenue drivers identified.

  • Ongoing restructuring and cost control measures are expected to further improve operating leverage.

  • Cash runway projected to last at least 12 months from June 30, 2025.

  • Addressing up to $56M of excess space through subleases, with $14M/quarter opportunity.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Ginkgo Bioworks earnings date

Logotype for Ginkgo Bioworks Holdings Inc
Q3 202511 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Ginkgo Bioworks earnings date

Logotype for Ginkgo Bioworks Holdings Inc
Q3 202511 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Ginkgo Bioworks Holdings, Inc, a biomolecular engineering company, develops biological manufacturing technologies to program cells for molecular manufacturing systems. Ginkgo Bioworks Holdings software engineering platform uses the widely used programming language Python and its library of bioinformatics functions and statistical methods. Ginkgo Bioworks' programs are designed to modify bacterial genes to make organic compounds such as vanillin, scents to produce civetone in bacteria, Beta-carotene and lycopene in yeast cells, gluconic acid in E. coli; and shikimic acid and artemisinic acid in yeast cells. The company sells its products to pharmaceutical companies including AstraZeneca Group and Eli Lilly & Co; chemical companies including Firmenich SA; flavor, aroma, and fragrance companies; craft breweries; and others.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage